Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,261 | 2,310 | 4,903 | 7,404 | 1,807 |
| Other current assets | 322 | 0 | 0 | 0 | 6 |
| TOTAL | $9,830 | $2,453 | $5,040 | $7,535 | $1,846 |
| Non-Current Assets | |||||
| PPE Net | 200 | 197 | 164 | 137 | 33 |
| Intangibles | 500 | 302 | 212 | 111 | 18 |
| Other Non-Current Assets | 61 | 56 | 53 | 43 | 36 |
| TOTAL | $761 | $554 | $429 | $292 | $87 |
| Total Assets | $10,591 | $3,007 | $5,469 | $7,826 | $1,933 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,033 | 792 | 548 | 1,017 | 352 |
| Accrued Expenses | 453 | 769 | 718 | N/A | N/A |
| Other current liabilities | 1,251 | N/A | N/A | N/A | N/A |
| TOTAL | $2,737 | $1,561 | $1,266 | $1,017 | $360 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 21 |
| Other Non-Current Liabilities | 0 | 6,462 | 0 | 0 | 0 |
| TOTAL | $N/A | $6,462 | $N/A | $N/A | $21 |
| Total Liabilities | $2,737 | $8,023 | $1,266 | $1,017 | $380 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,366 | 42,821 | 33,751 | 32,076 | 28,885 |
| Common Shares | 469 | 357 | 338 | 314 | 410 |
| Retained earnings | -85,954 | -67,567 | -57,487 | -45,656 | -38,593 |
| TOTAL | $7,854 | $-5,016 | $4,203 | $6,809 | $1,552 |
| Total Liabilities And Equity | $10,591 | $3,007 | $5,469 | $7,826 | $1,933 |